Icosapent Ethyl Capsule
Product Images NDC 16714-636

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Icosapent Ethyl (NDC 16714-636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 G-120s (1 G 120s)

This text provides information about a medication called Icosapent Ethyl Capsules, with each capsule containing 1 gram of Icosapent Ethyl. The usual adult dosage is not provided, but it refers to a package insert for complete dosage recommendations. The storage instructions include storing between 20° to 25°C (66° to 77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medication is manufactured by Ascent Pharmaceuticals, Inc. and packaged by Northstar. Additionally, it mentions keeping the medication out of reach of children.*

FDA Label Image

Tab 2 (Table 2)

The text provides data on the efficacy of Cosapent Ethyl compared to a placebo in a study involving 76 participants taking Cosapent Ethyl and 75 taking a placebo. The parameters analyzed include TG, LDL-C, Non-HDL-C, TC, HDL-C, VLDL-C, and Apo B, with information on baseline levels, % change, and confidence intervals. The results suggest potential improvements in several lipid markers, such as TG, LDL-C, and Non-HDL-C, for the group taking Cosapent Ethyl compared to the placebo group. Additionally, certain parameters like HDL-C and Apo B show comparable changes between the two groups.*

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.